Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
West Virginia University
OHSU Knight Cancer Institute
Alpha Tau Medical LTD.
Novartis
Turnstone Biologics, Corp.
Charite University, Berlin, Germany
University of Massachusetts, Worcester
McGill University Health Centre/Research Institute of the McGill University Health Centre
National Cancer Institute (NCI)
Apexigen America, Inc.
Clinigen, Inc.
Dana-Farber Cancer Institute
Nektar Therapeutics
Bristol-Myers Squibb
Idera Pharmaceuticals, Inc.
University Hospitals Cleveland Medical Center
Exicure, Inc.
Dynavax Technologies Corporation
Clinigen, Inc.
Centre Hospitalier Universitaire de Saint Etienne
Fox Chase Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Celldex Therapeutics
Aprea Therapeutics
Incyte Corporation
Stanford University
sigma-tau i.f.r. S.p.A.
Stanford University
New Mexico Cancer Research Alliance
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
The Cleveland Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hadassah Medical Organization
National Institutes of Health Clinical Center (CC)
Calando Pharmaceuticals
New Mexico Cancer Research Alliance
National Institutes of Health Clinical Center (CC)
DUSA Pharmaceuticals, Inc.
Case Comprehensive Cancer Center
Centre Hospitalier Universitaire de Nice